Bitcoin mining firm Bitfury announced plans to step beyond mining with a major new investment push. Related Reading: Bitcoin To $220K In 45 Days? Genius Makes Bold Claim, Promises To Build Churches Worldwide According to reports, the company will launch a $1 billion technology fund after 14 years focused mainly on emerging tech such as […]Bitcoin mining firm Bitfury announced plans to step beyond mining with a major new investment push. Related Reading: Bitcoin To $220K In 45 Days? Genius Makes Bold Claim, Promises To Build Churches Worldwide According to reports, the company will launch a $1 billion technology fund after 14 years focused mainly on emerging tech such as […]

Bitfury Says Goodbye To Mining, Hello To A $1 Billion Tech Fund

Bitcoin mining firm Bitfury announced plans to step beyond mining with a major new investment push.

According to reports, the company will launch a $1 billion technology fund after 14 years focused mainly on emerging tech such as artificial intelligence, quantum computing and decentralized identity systems.

The move signals a change of direction for the firm founded in 2011, which built its reputation on hardware and data center operations.

The $1B Fund Will Be Deployed Over Several Years

According to a press release, Bitfury intends to put roughly $200 million to work in the first year, with the remainder to follow over the next several years.

The firm says some capital could be deployed as early as Q4 2025. Company leaders told reporters that the money will come from a mix of returns from mining operations, past investment gains and outside backers.

Val Vavilov, the chief executive, has been named in reports as a key proponent of the shift.

The Fund Will Target AI, Quantum And Identity Tech

Bitfury has already invested in related infrastructure. Based on reports, the group helped build companies that handle data center cooling and AI hardware — assets that could support startups that need heavy compute.

Investors and founders in those sectors were quoted as saying Bitfury’s experience in physical infrastructure gives it a practical edge when backing capital-hungry projects.

Still, success is not guaranteed. Finding the right startups will be hard work, and competition from established venture firms is strong.

Why The Company Is Changing Focus

According to the company’s public comments, leaders see a link between secure, transparent systems and next-generation AI tools.

They argue that building technology that protects user identity and privacy will be important as AI systems grow more powerful.

The fund will emphasize what Bitfury calls “ethical emerging technologies,” a phrase the company uses to describe projects that combine technical innovation with safeguards for users.

Existing Strengths And Risks

Bitfury’s past moves show it can build hardware and run big operations. Reports note its ties to outfits working on immersion cooling and AI chips, which could make the company a useful backer for founders who need both money and infrastructure.

But running a large investment program is different from running mines. Picking winners in AI and quantum computing is competitive. Market swings, fast technology change, and unclear rules around crypto and identity systems add to the challenge.

Governance, Timing And What Comes Next

Based on reports, the fund’s governance model and detailed investment rules have not been fully public. Observers say those details will matter to prospective startups and co-investors.

Bitfury plans to move cautiously at first while still making a sizable first-year commitment. Some investors welcomed the news, while other analysts urged caution.

For now, Bitfury’s plan is clear in scale and ambition: $1 billion, early deployment in Q4 2025, and a first-year push of $200 million. How well the firm adapts from miner to investor will be watched closely by the tech and crypto communities.

Featured image from Shutterstock, chart from TradingView

Market Opportunity
HELLO Logo
HELLO Price(HELLO)
$0.002674
$0.002674$0.002674
-1.18%
USD
HELLO (HELLO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26